Cargando…

The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study

PURPOSE: To understand the perspectives of people with type 2 diabetes (T2D) on safely reaching near normoglycemia, defined as a glycated hemoglobin A1c (HbA1c) value of <6%. HbA1c indicates the average blood sugar level over the past few months. PATIENTS AND METHODS: This cross-sectional online...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhorn, Heather L, Ross, Melissa M, Shinde, Shraddha, Thieu, Vivian Thuyanh, Boye, Kristina S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357561/
https://www.ncbi.nlm.nih.gov/pubmed/35958885
http://dx.doi.org/10.2147/PPA.S366966
_version_ 1784763736806916096
author Gelhorn, Heather L
Ross, Melissa M
Shinde, Shraddha
Thieu, Vivian Thuyanh
Boye, Kristina S
author_facet Gelhorn, Heather L
Ross, Melissa M
Shinde, Shraddha
Thieu, Vivian Thuyanh
Boye, Kristina S
author_sort Gelhorn, Heather L
collection PubMed
description PURPOSE: To understand the perspectives of people with type 2 diabetes (T2D) on safely reaching near normoglycemia, defined as a glycated hemoglobin A1c (HbA1c) value of <6%. HbA1c indicates the average blood sugar level over the past few months. PATIENTS AND METHODS: This cross-sectional online quantitative survey of people with T2D asked about the current impacts of T2D, the anticipated benefits of safely achieving near normoglycemia among participants with a current HbA1c ≥6%, or the actual benefits of safely achieving near normoglycemia among participants who had an HbA1c <6%. Participants reported on specific areas of psychological/emotional impact of T2D and the psychological/emotional benefits of achieving near normoglycemia. RESULTS: Participants (N = 1000; United States = 500 and United Kingdom = 500) were 53.1% male and had a mean age of 62.9 years (SD = 13.3). The majority reported that the current HbA1c ≥6% (81.2%) and 49.2% had been diagnosed more than 10 years ago. The vast majority of participants (>90%) indicated that achieving near normoglycemia was meaningful, with 95% of the participants indicating that achieving near normoglycemia would be of somewhat or extreme importance to them. In total, 93.8% of participants with a current HbA1c ≥6% and 80.3% of those with a current HbA1c <6% anticipated/reported having experienced improvements as a result of achieving near normoglycemia. Among those who experienced or anticipated positive psychological/emotional impacts (n = 247), the most commonly reported impacts included less worry about future diabetes-related complications (79.8%), feeling in control over one’s life (72.9%), and overall health-related quality of life (59.9%). CONCLUSION: Achieving near normoglycemia is both meaningful and important to the majority of people with T2D, including both those who have and those who have not experienced reaching near normoglycemia. A wide range of specific impacts, including psychological/emotional concepts, are experienced by people with T2D, many of which may be improved through achieving near normoglycemia.
format Online
Article
Text
id pubmed-9357561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93575612022-08-10 The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study Gelhorn, Heather L Ross, Melissa M Shinde, Shraddha Thieu, Vivian Thuyanh Boye, Kristina S Patient Prefer Adherence Original Research PURPOSE: To understand the perspectives of people with type 2 diabetes (T2D) on safely reaching near normoglycemia, defined as a glycated hemoglobin A1c (HbA1c) value of <6%. HbA1c indicates the average blood sugar level over the past few months. PATIENTS AND METHODS: This cross-sectional online quantitative survey of people with T2D asked about the current impacts of T2D, the anticipated benefits of safely achieving near normoglycemia among participants with a current HbA1c ≥6%, or the actual benefits of safely achieving near normoglycemia among participants who had an HbA1c <6%. Participants reported on specific areas of psychological/emotional impact of T2D and the psychological/emotional benefits of achieving near normoglycemia. RESULTS: Participants (N = 1000; United States = 500 and United Kingdom = 500) were 53.1% male and had a mean age of 62.9 years (SD = 13.3). The majority reported that the current HbA1c ≥6% (81.2%) and 49.2% had been diagnosed more than 10 years ago. The vast majority of participants (>90%) indicated that achieving near normoglycemia was meaningful, with 95% of the participants indicating that achieving near normoglycemia would be of somewhat or extreme importance to them. In total, 93.8% of participants with a current HbA1c ≥6% and 80.3% of those with a current HbA1c <6% anticipated/reported having experienced improvements as a result of achieving near normoglycemia. Among those who experienced or anticipated positive psychological/emotional impacts (n = 247), the most commonly reported impacts included less worry about future diabetes-related complications (79.8%), feeling in control over one’s life (72.9%), and overall health-related quality of life (59.9%). CONCLUSION: Achieving near normoglycemia is both meaningful and important to the majority of people with T2D, including both those who have and those who have not experienced reaching near normoglycemia. A wide range of specific impacts, including psychological/emotional concepts, are experienced by people with T2D, many of which may be improved through achieving near normoglycemia. Dove 2022-08-03 /pmc/articles/PMC9357561/ /pubmed/35958885 http://dx.doi.org/10.2147/PPA.S366966 Text en © 2022 Gelhorn et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gelhorn, Heather L
Ross, Melissa M
Shinde, Shraddha
Thieu, Vivian Thuyanh
Boye, Kristina S
The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
title The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
title_full The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
title_fullStr The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
title_full_unstemmed The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
title_short The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study
title_sort benefits of safely achieving near normoglycemia from the perspective of people with type 2 diabetes: a quantitative survey study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357561/
https://www.ncbi.nlm.nih.gov/pubmed/35958885
http://dx.doi.org/10.2147/PPA.S366966
work_keys_str_mv AT gelhornheatherl thebenefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT rossmelissam thebenefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT shindeshraddha thebenefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT thieuvivianthuyanh thebenefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT boyekristinas thebenefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT gelhornheatherl benefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT rossmelissam benefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT shindeshraddha benefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT thieuvivianthuyanh benefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy
AT boyekristinas benefitsofsafelyachievingnearnormoglycemiafromtheperspectiveofpeoplewithtype2diabetesaquantitativesurveystudy